D2L Clinical Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.90 M
as on 15-12-2024
About D2L Clinical Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kode Kiran, Deepak Harikrishnan, Shekhar Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900KA2014PTC075357
- Company No.
075357
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2014
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at D2L Clinical Solutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shekhar Gupta  | Whole-Time Director | 15-Jul-2014 | Current |
| Deepak Harikrishnan | Whole-Time Director | 15-Jul-2014 | Current |
| Kode Kiran | Whole-Time Director | 15-Jul-2014 | Current |
| Marella Ravikant | Whole-Time Director | 15-Jul-2014 | Current |
Financial Performance of D2L Clinical Solutions.
D2L Clinical Solutions Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of D2L Clinical Solutions?
In 2017, D2L Clinical Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
D2l Pharma Research Solutions Private LimitedActive 17 years 5 monthsKode Kiran, Deepak Harikrishnan and 2 more are mutual person
- Arunachalamm Renewable Energy Private LimitedActive 10 years 10 months
Kode Kiran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 May 2020 | ₹0.90 M | Satisfied |
How Many Employees Work at D2L Clinical Solutions?
Unlock and access historical data on people associated with D2L Clinical Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D2L Clinical Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D2L Clinical Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
